ArticleACS omega2026
Optimization of the Quantum-Si Platinum Single-Molecule Protein Sequencing Platform Toward Improved Complex-Matrix Protein Identification.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Proteins are a class of macromolecules with essential roles in processes and structures associated with life. Protein sequencing technologies are, therefore, fundamental for understanding cell metabolic pathways, disease mechanisms, and how pathogenic agents and toxins function. Emerging next-generation protein sequencing (NGPS) technologies promise a dramatic improvement in proteomics, enabling the identification of pathogens and toxins with unparalleled sensitivity and precision. The Quantum-Si (QSi) Platinum Sequencer is an emerging single-molecule protein sequencing technology capable of single amino acid resolution. In this work, we conducted significant optimization of the QSi protein library preparation protocol, reducing sample preparation time from 32 to 10 h without sacrificing substantial sequencing quality, allowing for a sample-to-answer timeline in less than 24 h. The modified protocol was applied for analyzing a set of proteins including 16 single-domain antibodies with diverse sequences and a nontoxic derivative of staphylococcal enterotoxin B. We were further able to determine the library dilution threshold: losing the ability to sequence beyond a 100× dilution. Finally, we were able to successfully obtain protein sequences within a crude bacterial cell lysate background, demonstrating the effectiveness of sequencing in complex protein mixtures. Improvements in sequencing chemistry and data processing may soon lessen or eliminate the dependence on reference sequences, a current obstacle for efficiently characterizing unknown proteins. By further condensing and optimizing library preparation, this technique presents a potential application for proteomics that requires rapid characterization of highly complex biological systems, significantly improving protein-based diagnostic technologies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.